The Association of Clinical Research Organizations (ACRO) announced the election of Peyton Howell, Chief Operating & Growth Officer at Parexel, as the new Chair of the association, effective January 1, 2024. Joining her in leadership positions are Lisa Moneymaker, elected as Vice Chair; Mike Crowley, Secretary; and Ari Feldman, re-elected Treasurer.

Howell brings extensive experience in the healthcare industry, having led Parexel to notable business growth and spearheading a patient-focused strategy. She has over 25 years of leadership experience and a record of accomplishment at AmerisourceBergen, now known as Cencora, where she oversaw a $50B business unit and served as President for Health Systems and Specialty Care Solutions. A founder of Lash Group, Howell grew the company significantly before its acquisition by AmerisourceBergen and served as its President for a decade. She also holds a Master’s in Healthcare Administration from Ohio State University and was honored as a Luminary by the Healthcare Businesswomen’s Association in 2020. Additionally, Howell has been a board member of Tandem Diabetes Care and represented Parexel on ACRO’s Board since 2020.

Howell acknowledged the industry’s challenges in 2023 and commended ACRO member companies for their patient-centric approach and adapting and innovating practices to continue transforming clinical trials. She expressed enthusiasm for leading ACRO into the future, aiming to enhance collaboration across the clinical research enterprise and achieve optimized development of new therapies for patients globally.

ACRO has expanded its membership, welcoming Advarra, a site-centric technology company, and YPrime, an eClinical trial management solutions firm. Lisa Moneymaker noted that their inclusion reflects ACRO’s evolution to represent CROs and clinical technology companies. She emphasized the importance of initiatives like ACRO’s newly formed AI/ML Committee, which offers a platform for industry leaders to engage in discussions on pressing topics and catalyze industry change.

ACRO serves as a unified voice for clinical research and technology organizations, engaging with regulators and policymakers to educate stakeholders and influence policies promoting efficient, effective, and safe conduct of clinical research.

Source link

author avatar
Ferry Darma
Ferry Darma is Director of Media Relations at The Clinical Trial Vanguard. Ferry, a computer data scientist, focuses on the latest clinical trial industry news and trends.